208 related articles for article (PubMed ID: 29664549)
1. Evaluation of soluble concentration Fas and Fas ligand in maternal and cord blood 3rd trimester of pregnancy.
Karowicz-Bilińska A; Kowalska-Koprek U; Estemberg D; Sikora-Szubert A
Ginekol Pol; 2018; 89(3):142-146. PubMed ID: 29664549
[TBL] [Abstract][Full Text] [Related]
2. Soluble fas antigen and soluble fas ligand in intrauterine growth restriction.
Briana DD; Baka S; Boutsikou M; Liosi S; Vraila VM; Gourgiotis D; Hassiakos D; Malamitsi-Puchner A
Neonatology; 2010; 97(1):31-5. PubMed ID: 19590243
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of tissue metalloproteinase inhibitor TIMP-1 and Survivin levels during third trimester pregnancy - a preliminary report.
Karowicz-Bilińska A; Kowalska-Koprek U; Estemberg D; Sikora-Szubert A
Ginekol Pol; 2017; 88(4):198-204. PubMed ID: 28509321
[TBL] [Abstract][Full Text] [Related]
4. Soluble Fas antigen and soluble Fas ligand in early neonatal life.
Sarandakou A; Protonotariou E; Rizos D; Soubassi L; Malamitsi-Puchner A
Early Hum Dev; 2003 Dec; 75(1-2):1-7. PubMed ID: 14652155
[TBL] [Abstract][Full Text] [Related]
5. Serum levels of soluble Fas and Fas ligand in pregnant women who smoke.
Hasan S; Alshaikh B; Yusuf K
Am J Reprod Immunol; 2021 Jun; 85(6):e13382. PubMed ID: 33247994
[TBL] [Abstract][Full Text] [Related]
6. Associations of serum soluble Fas and Fas ligand (FasL) with outcomes in systemic lupus erythematosus.
Vincent FB; Kandane-Rathnayake R; Koelmeyer R; Harris J; Hoi AY; Mackay F; Morand EF
Lupus Sci Med; 2020 Jun; 7(1):. PubMed ID: 32546562
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the maternal and umbilical vein serum sFas/sFasL system in pregnancies complicated by preeclampsia with intrauterine growth retardation.
Laskowska M; Laskowska K; Leszczyńska-Gorzelak B; Oleszczuk J
Eur J Obstet Gynecol Reprod Biol; 2006 Jun; 126(2):155-9. PubMed ID: 16169656
[TBL] [Abstract][Full Text] [Related]
8. Soluble Fas and Fas-ligand levels in mid-trimester amniotic fluid and their associations with severe small for gestational age fetuses: a prospective observational study.
Vrachnis N; Dalainas I; Papoutsis D; Samoli E; Rizos D; Iliodromiti Z; Siristatidis C; Tsikouras P; Creatsas G; Botsis D
J Reprod Immunol; 2013 Jun; 98(1-2):39-44. PubMed ID: 23582102
[TBL] [Abstract][Full Text] [Related]
9. Limited expression of Fas and Fas ligand in fetal nucleated erythrocytes isolated from first trimester maternal blood.
Sohda S; Samura O; Johnson KL; Falco VM; Elmes RS; Bianchi DW
Prenat Diagn; 2002 Dec; 22(13):1213-8. PubMed ID: 12478636
[TBL] [Abstract][Full Text] [Related]
10. Apoptosis markers soluble Fas (sFas), Fas Ligand (FasL) and sFas/FasL ratio in patients with bacteremia: a prospective cohort study.
Huttunen R; Syrjänen J; Vuento R; Laine J; Hurme M; Aittoniemi J
J Infect; 2012 Mar; 64(3):276-81. PubMed ID: 22207003
[TBL] [Abstract][Full Text] [Related]
11. Fas and Fas ligand expression in maternal blood and in umbilical cord blood in preeclampsia.
Kuntz TB; Christensen RD; Stegner J; Duff P; Koenig JM
Pediatr Res; 2001 Dec; 50(6):743-9. PubMed ID: 11726734
[TBL] [Abstract][Full Text] [Related]
12. Increased serum sFas, sTRAIL, and reduced sFasL in juvenile-onset systemic lupus erythematosus.
Liphaus BL; Kiss MHB; Carrasco S; Palmeira P; Goldenstein-Schainberg C; Carneiro-Sampaio M
Clin Rheumatol; 2017 Dec; 36(12):2847-2852. PubMed ID: 28378099
[TBL] [Abstract][Full Text] [Related]
13. Influence of levothyroxine treatment on serum levels of soluble Fas (CD95) and Fas Ligand (CD95L) in chronic autoimmune hypothyroidism.
Nabipour I; Kalantarhormozi M; Assadi M; Jafari SM; Gharibi M; Ahmadi E; Sanjdideh Z
Endocrine; 2010 Dec; 38(3):406-11. PubMed ID: 21042884
[TBL] [Abstract][Full Text] [Related]
14. [Expression of Fas and FasL in serum and placenta of preeclamptic pregnancy and its significance].
Hu WS; Wang ZP; Dong MY; Wang HZ
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2005 Nov; 34(6):499-502. PubMed ID: 16331809
[TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinases and soluble Fas/FasL system as novel regulators of apoptosis in children and young adults on chronic dialysis.
Musiał K; Zwolińska D
Apoptosis; 2011 Jul; 16(7):653-9. PubMed ID: 21516345
[TBL] [Abstract][Full Text] [Related]
16. Concentrations of soluble Fas in maternal serum and amniotic fluid during uncomplicated pregnancies.
Malamitsi-Puchner A; Sarandakou A; Papagianni V; Protonotariou E; Tziotis J; Botsis D
J Soc Gynecol Investig; 2003 Apr; 10(3):158-60. PubMed ID: 12699879
[TBL] [Abstract][Full Text] [Related]
17. Soluble Fas might serve as a diagnostic tool for gastric adenocarcinoma.
Boroumand-Noughabi S; Sima HR; Ghaffarzadehgan K; Jafarzadeh M; Raziee HR; Hosseinnezhad H; Moaven O; Rajabi-Mashhadi MT; Azarian AA; Mashhadinejad M; Tavakkol-Afshari J
BMC Cancer; 2010 Jun; 10():275. PubMed ID: 20534173
[TBL] [Abstract][Full Text] [Related]
18. Prolonged intrathecal release of soluble Fas following severe traumatic brain injury in humans.
Lenzlinger PM; Marx A; Trentz O; Kossmann T; Morganti-Kossmann MC
J Neuroimmunol; 2002 Jan; 122(1-2):167-74. PubMed ID: 11777556
[TBL] [Abstract][Full Text] [Related]
19. [The effect of tobacco smoking on serum concentration of selected angiogenic factors and somatomedin C in pregnant women and umbilical cord blood].
Chełchowska M; Gajewska J; Ambroszkiewicz J; Lewandowski L; Maciejewski TM; Ołtarzewski M; Laskowska-Klita T
Przegl Lek; 2013; 70(10):800-4. PubMed ID: 24501799
[TBL] [Abstract][Full Text] [Related]
20. Tissue polypeptide specific antigen and soluble Fas during normal pregnancy and early life.
Protonotariou E; Rizos D; Malamitsi-Puchner A; Sarandakou A; Botsis D
In Vivo; 2006; 20(6B):901-5. PubMed ID: 17203787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
